Physician profile
Ismail A H Bokhari
NPI 1205050655
$4,230.15
in general payments reported to CMS, 2019-2025
20 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $337 · 2021: $281 · 2022: $227 · 2023: $16.46 · 2024: $192 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,617 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,617.07 |
| Food and Beverage | $675.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,933.42 | 2025 | Corevalve Evolut R, Endurant Iis |
| Boston Scientific Corporation | $519.71 | 2019-2024 | Avvigo Guidance System |
| Terumo Medical Corporation | $298.78 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $238.24 | 2019-2021 | |
| Abiomed | $226.55 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $188.88 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $150.47 | 2022-2025 | Assure Wcd |
| Biotronik INC. | $123.33 | 2019 | |
| Medtronic Vascular, INC. | $101.35 | 2019 | |
| Asahi Intecc USA, INC. | $89.16 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $76.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $63.30 | 2019-2020 | |
| Philips North America LLC | $57.70 | 2019 | |
| Ge Healthcare | $34.75 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $30.67 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.04 | 2024 | Verquvo |
| Shockwave Medical, INC | $20.32 | 2025 | |
| Baxter Healthcare | $16.46 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bardy Diagnostics, INC. | $15.72 | 2022 | |
| Cardiovascular Systems INC. | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ismail Bokhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.